SCHEMBL7563170

SCHEMBL7563170

CCOC(=O)CNC(C)C(CCc1ccccc1)c1ccc(Oc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 1/20 0.42
LMNA P02545 3/20 0.41
MAPT P10636 1/20 0.41
AKR1C3 P42330 4/20 0.40
F2 P00734 2/20 0.39
F10 P00742 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
F7 P08709 1/20 0.39
F3 P13726 1/20 0.39
PRSS3 P35030 1/20 0.39
FFAR1 O14842 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7563408 0.91 NPSR1 (0.47) NPSR1SMN1; SMN2MEN1KMT2APOLB
SCHEMBL7561017 0.85 SMN1; SMN2 (0.45) NPSR1SMN1; SMN2F2F10
SCHEMBL7561981 0.81 SMN1; SMN2 (0.47) SMN1; SMN2LMNAFFAR1FFAR4ACACB
SCHEMBL7563386 0.80 NPSR1 (0.43) NPSR1SMN1; SMN2MEN1KMT2APOLB
SCHEMBL7561006 0.79 SMN1; SMN2 (0.44) NPSR1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL7561992 0.78 NPSR1 (0.43) NPSR1SMN1; SMN2MEN1KMT2APOLB
SCHEMBL7570883 0.76 LMNA (0.46) NPSR1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL7561384 0.75 ALDH1A1 (0.43) SMN1; SMN2MEN1KMT2AFFAR1ACACB
SCHEMBL7567148 0.75 NPC1 (0.38) SMN1; SMN2MAPTF2F10
SCHEMBL10364816 0.69 NPSR1 (0.48) NPSR1SMN1; SMN2MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882703-B1 CYCLIC AMIC ACID DERIVATIVES BANYU PHARMA CO LTD (JP) 2002-08-14 EP disclosed
US-6011174-A INHIBIT PROTEIN-FARNESYL TRANSFERASE (PFT) IN VIVO THEREBY TO SUPPRESS FUNCTION OF ONCOGENE PROTEIN RAS AND THUS PRESENT ANTITUMOR ACTIVITIES, BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-01-04 US disclosed
EP-0882703-A1 CYCLIC AMIC ACID DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed